Current Month 2006
Article Features
  More Common Associations Found between BRCA1 and BRCA2 Mutations and Cancer
Chemotherapy Temporarily Affects the Structures of the Human Brain
Order of chemotherapy, radiation has no effect on breast cancer survival
Bias in Who Gets Screened for Breast Cancer
New Breast CT Scanner Unveiled
Reduced Dietary Fat Intake May Decrease Breast Cancer Recurrence
Elasticity Imaging Identifies Cancers and Reduces Breast Biopsies
Higher Physical Activity Associated with Reduced Risk of Breast Cancer
Herceptin Approved for Early Treatment of HER2-positive Breast Cancer
New Gamma Camera Technique for the Detection of Small Breast Tumors
1 in 5 Early-Stage Breast Cancer Patients May Not Follow Hormonal Therapy Plan
Hypnosis Helps Women Cope with Breast Biopsy
Use of Mammograms in Men Rising But Not Warranted
Program to Freeze Women’s Ovaries to Preserve Fertility after Cancer
Overweight Young Women Have Reduced Risk of Developing Breast Cancer Before Menopause
Protein in the Diet and Cancer Risk
Breast Cancer Radiation Procedure Gives Women More Options
Second Opinion Yields Treatment Change for Half of Patients
Telemedicine Improves Breast Screenings for Rural Indian Reservations
Novel Vaccine Shows Promise Against Early-Stage Breast Cancer
Pro-vitamin E Shown to be Active Against Breast Cancer Cells

Decline in Breast Cancer Cases Likely Linked to Reduced Use of Hormone Replacement

In 2003, breast cancer incidence in the United States dropped sharply, and this decline may largely be due to the fact that millions of older women stopped using hormone replacement therapy (HRT) in 2002, according to a new analysis led by researchers at The University of Texas M. D. Anderson Cancer Center.

At the 29th annual San Antonio Breast Cancer Symposium, the investigators report that there was an overall 7 percent relative decline in breast cancer incidence between 2002 and 2003, and that the steepest decline - 12 percent - occurred in women between ages 50-69 diagnosed with estrogen receptor positive (ER-positive) breast cancer. This is the kind of breast cancer that is dependent on hormones for tumor growth.

From this, the researchers conclude that as many as 14,000 fewer women were diagnosed with breast cancer in 2003 than in 2002, a year in which the American Cancer Society estimates 203,500 new cases of breast cancer were diagnosed.

"It is the largest single drop in breast cancer incidence within a single year I am aware of," says Peter Ravdin, M.D., Ph.D., a research professor in the Department of Biostatistics at M. D. Anderson.

Read More of the Main Article

Visit the Ezine

Visit the BreastCenter

Visit the Quality Corner
Avon Breast Cancer Crusade - AVON the company for women

  This website is supported in part by an unrestricted educational grant provided by Avon